Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Oncimmune (ONC)

Price 15.15p on 22-10-2024 at 16:30:00
Change -0.05p -0.33%
Buy 15.60p
Sell 14.70p
Buy / Sell ONC Shares
Last Trade: Unknown 167,976.00 at 15.15p
Day's Volume: 216,081
Last Close: 15.15p
Open: 15.20p
ISIN: GB00BYQ94H38
Day's Range 0.00p - 0.00p
52wk Range: 9.35p - 30.20p
Market Capitalisation: £11m
VWAP: 15.11735p
Shares in Issue: 74m

Recent Trades History Oncimmune (ONC)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 167,976 15.15p OTC Trade
17:07:36 - 22-Oct-24
Sell* 6,333 14.862p Ordinary
15:29:01 - 22-Oct-24
Sell* 13 14.70p SI Trade
13:58:34 - 22-Oct-24
Sell* 948 14.75p Ordinary
12:21:15 - 22-Oct-24
Sell* 2,300 14.862p Ordinary
12:19:22 - 22-Oct-24
Sell* 15,000 14.79p Ordinary
11:03:10 - 22-Oct-24
Buy* 6,578 15.20p Ordinary
09:21:19 - 22-Oct-24
Buy* 100 15.60p SI Trade
08:53:02 - 22-Oct-24
Sell* 16,833 15.20p Ordinary
08:47:52 - 22-Oct-24
Unknown* 107,976 15.25p Negotiated Trade
16:35:28 - 21-Oct-24

Share Price History for Oncimmune

Time period:
to
Date Open High Low Close Volume

Share News for Oncimmune

UPDATE: Oncimmune raises GBP2.2 million in equity as planned

21st Oct 2024 12:30

Oncimmune Holdings PLC - Leeds, England-based autoantibody profiling research services to pharmaceutical and biotechnology industry to enable delivery of precision medicine - Raises GBP2.2 million from placing of 12.0 million new shares and subscription for 2.3 million more, all at 15 pence. The results of the placing, run as an accelerated bookbuild by brokers Cavendish and Zeus, is in line with plans set out early Friday. Oncimmune also plans a retail share offer of up to 2.0 million shares to raise an additional GBP300,000. Read More

IN BRIEF: Oncimmune converts debt and offers shares in growth push

18th Oct 2024 12:44

Oncimmune Holdings PLC - Nottingham, England-based autoantibody profiling research services to pharmaceutical and biotechnology industry to enable delivery of precision medicine - Recapitalises two-thirds of its debt and launches a new share offer to raise funds to support recent contract wins and prepare for its "next stage of growth". Read More

Oncimmune expects "substantial" revenue growth following contract wins

9th Sep 2024 11:42

(Alliance News) - Oncimmune Holdings PLC said on Monday that it has entered into five new contracts since its last update in May this year, which are set to substantially grow revenue for financial 2025. Read More

Oncimmune Holdings agrees new contract valued at USD700,000

2nd Sep 2024 17:35

(Alliance News) - Oncimmune Holdings PLC announced on Monday that it has won a new contract with a top 10 global pharma company, for a project focused on a rare immune-related disease. Read More

TRADING UPDATES: Tan Delta signs contract; Earnz loss widens

9th Aug 2024 17:15

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and Friday and not separately reported by Alliance News: Read More

FTSE 100 Latest
Value8,306.54
Change-11.70

Login to your account

Forgot Password?

Not Registered